Flexible Sample Size Considerations Using Information-Based Interim Monitoring

Kim K, Tsiatis AA. Study duration for clinical trials with survival response and early stopping rule. Biometrics. 1990;46:81–92.

Scharfstein DO, Tsiatis AA. The use of simulation and bootstrap in information-based group sequential studies. Stat Med. 1998;17:75–87.

Scharfstein DO, Tsiatis AA, Robins JM. Semiparametric efficiency and its implication on the design and analysis of group-sequential studies. J Am Stat Assoc. 1997;92:1342–1350.

EaSt: Software for design and interim monitoring of group sequential clinical trials. Cambridge, MA: Cytel Software Corporation; 2000.

Wang SK, Tsiatis AA. Approximately optimal one-parameter boundaries for group sequential trials. Biometrics. 1987;43:193–199.

O’Brien PC, Fleming TR. A multiple testing procedure for clinical trials. Biometrics. 1979;35:549–556.

Pocock SJ. Group sequential methods in the design and analysis of clinical trials. Biometrika. 1977;64:191–199.

Lan KKG, DeMets DL. Discrete sequential boundaries for clinical trials. Biometrika. 1983;70:659–663.

Armitage P, McPherson CK, Rowe BC. Repeated significance tests on accumulating data. J R Stat Soc A. 1969;132:232–244.

Self SG, Mauritsen RH, Ohara J. Power calculation for likelihood ratio tests in generalized linear models. Biometrics. 1992;48:31–39.

Facey KM. A sequential procedure for a Phase II efficacy trial in hypercholesterolemia. Control Clinical Trials. 1992;13:122–133.

Haybittle JL. Repeated assessment of results in clinical trials of cancer treatment. Br J Radiology. 1971;44: 793–797.